Scientists have recently announced that there may be a positive side effect to the drugs that could help patients tackle ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Adding an anti-obesity medication just one month after behavioral therapy begins-rather than waiting the currently recommended six months-can more than double weight loss for patients who struggle ...

The arrival of truly effective weight loss drugs marks the answer to prayers, the solution many have been awaiting desperately for decades.. Drugs such as Ozempic, Wegovy and Mounjaro can help ...

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men. What’s not clear is why.